Chiron Corp.

Chiron Corp.: "

Pablo Valenzuela, vice president of R&D at Chiron Corp., faces several choices for how to allocate scarce resources across several promising projects. These choices will determine Chiron's position in several emerging biotechnology and diagnostic markets, including tests for hepatitis C, HIV infection, and others. Valenzuela must examine Chiron's capacity, its strategy, and the character of the opportunity, including the impact of these choices on joint venture partners.

Learning Objective: To address issues in aggregate project planning and development strategy. Illustrates the interaction between development capacity, business strategy, and project opportunities in a rapidly changing technical and commercial environment.

"